Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases.

[1]  P. Gaffney,et al.  Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus , 2011, Annals of the rheumatic diseases.

[2]  M. Mayes,et al.  Association Study of ITGAM, ITGAX, and CD58 Autoimmune Risk Loci in Systemic Sclerosis: Results from 2 Large European Caucasian Cohorts , 2011, The Journal of Rheumatology.

[3]  R. Madhok,et al.  Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis , 2011, Annals of the rheumatic diseases.

[4]  J. Kere,et al.  Polymorphisms of the ITGAM Gene Confer Higher Risk of Discoid Cutaneous Than of Systemic Lupus Erythematosus , 2010, PloS one.

[5]  J. Anaya.  The autoimmune tautology , 2010, Arthritis Research & Therapy.

[6]  J. Anaya,et al.  HLA-Class II in Latin American patients with type 1 diabetes. , 2010, Autoimmunity reviews.

[7]  A. Georgescu,et al.  IL-17 in cutaneous lupus erythematosus. , 2010, European journal of internal medicine.

[8]  R. Kimberly,et al.  Pathways: Strategies for susceptibility genes in SLE. , 2010, Autoimmunity reviews.

[9]  J. Anaya,et al.  Factors influencing polyautoimmunity in systemic lupus erythematosus. , 2010, Autoimmunity reviews.

[10]  M. Petri,et al.  ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry , 2009, Annals of the rheumatic diseases.

[11]  T. Merriman,et al.  No evidence for association of the systemic lupus erythematosus-associated ITGAM variant, R77H, with rheumatoid arthritis in the Caucasian population. , 2009, Rheumatology.

[12]  G. Herrero-Beaumont,et al.  Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors. , 2009, Arthritis and rheumatism.

[13]  J. Molineros,et al.  Admixture in Hispanic-Americans: Its impact on ITGAM association and implications for admixture mapping in SLE , 2009, Genes and Immunity.

[14]  P. Gregersen,et al.  Evaluation of imputation-based association in and around the integrin-alpha-M (ITGAM) gene and replication of robust association between a non-synonymous functional variant within ITGAM and systemic lupus erythematosus (SLE). , 2009, Human molecular genetics.

[15]  S J Nelson,et al.  Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. , 2009, Brain : a journal of neurology.

[16]  J. Anaya,et al.  Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus. , 2008, Autoimmunity reviews.

[17]  Wei Chen,et al.  A nonsynonymous functional variant in integrin-αM (encoded by ITGAM) is associated with systemic lupus erythematosus , 2008, Nature Genetics.

[18]  Kristin K. Nicodemus,et al.  catmap: Case-control And TDT Meta-Analysis Package , 2008, BMC Bioinformatics.

[19]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[20]  Yufang Shi,et al.  CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiation , 2007, The Journal of experimental medicine.

[21]  S. Fagerholm,et al.  alpha-Chain phosphorylation of the human leukocyte CD11b/CD18 (Mac-1) integrin is pivotal for integrin activation to bind ICAMs and leukocyte extravasation. , 2006, Blood.

[22]  Juan-Manuel Anaya,et al.  Is there a Common Genetic Basis for Autoimmune Diseases? , 2006, Clinical & developmental immunology.

[23]  J. Anaya,et al.  Genetic Basis of Sjögren's Syndrome. How Strong is the Evidence? , 2006, Clinical & developmental immunology.

[24]  G. Abecasis,et al.  Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies , 2006, Nature Genetics.

[25]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[26]  R. Jonsson,et al.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.

[27]  L. McCormick,et al.  Murine Sclerodermatous Graft-Versus-Host Disease, a Model for Human Scleroderma: Cutaneous Cytokines, Chemokines, and Immune Cell Activation1 , 2002, The Journal of Immunology.

[28]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[29]  A. Fasano,et al.  Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. , 2001, Gastroenterology.

[30]  Yan Zhang,et al.  Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. , 1999, Journal of immunology.

[31]  M. Arakawa,et al.  Flowcytometric analysis of bronchoalveolar lavage fluid cells in polymyositis/dermatomyositis with interstitial pneumonia , 1999, Respirology.

[32]  D. Geissler,et al.  Renal expression of intercellular adhesion molecule-1 in different forms of glomerulonephritis. , 1991, Clinical science.

[33]  L. Klareskog,et al.  Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis. , 1990, Annals of the rheumatic diseases.

[34]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[35]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[36]  R. Winchester,et al.  Surface expression of gp165/95, the complement receptor CR3, as a marker of disease activity in systemic lupus erythematosus , 1988 .

[37]  R. Winchester,et al.  Surface expression of Gp 165/95, the complement receptor CR3, as a marker of disease activity in systemic Lupus erythematosus. , 1988, Clinical immunology and immunopathology.

[38]  V. D’Agati,et al.  Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis. , 1986, Kidney international.

[39]  Googe Mc.  The Arthritis Foundation. , 1984 .

[40]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.